Vitrana adds another Milestone to its ongoing successful implementation of TransformPV with the global clientele, Otsuka Pharmaceutical Development & Commercialization, Inc. “Goes Live” with TransformPV for meeting FDA eMDR requirement. Otsuka, the leading pharmaceuticals company has implemented Vitrana’s TransformPV solution to meet its R3 eMDR regulatory requirements. TransformPV has enabled Otsuka to: